Fetal liver and thymus transplantation can be successfully employed for the treatment of severe combined immunodeficiency disease. In virtually all cases, donor and recipient cells are HLA mismatched. In a patient suffering from a severe combined immunodeficiency disease, full immunological reconstitution was obtained after fetal liver and thymus transplantation. HLA typing revealed that the patient's T cells were of donor origin, while the B cells and monocytes were of host origin. Despite this complete HLA mismatch, the patient was found to mount a subnormal to normal antibody response in vivo. This finding is in contrast with the concept that antigen recognition by T cells is major histocompatibility complex (MHC) restricted. To define the mechanism responsible for this in vivo antibody response, antibody production by peripheral blood mononuclear cells from the patient was tested in vitro after in vivo booster. The in vitro anti-tetanus toxoid antibody production was similar to that of the control group. In addition, specific proliferative responses to tetanus toxoid were obtained. Immunoglobulin allotype determination showed that antibodies were synthetized by host B cells. The results of the present study indicate that transplanted T lymphocytes and recipient cells cooperate despite complete HLA mismatch.
Introduction
Severe combined immunodeficiency (SCID)' can be treated by bone marrow transplantation (1) . As an alternative, especially when no histocompatible marrow donor is available, fetal liver and thymus transplantation (FLTT) can be successfully em-ployed (1) . In (2) . Ag recognition by helper T cells is restricted by cell surface molecules encoded by the I region on the H2 complex in mice, or by its human homologue, the HLA-D region (3) .
Cooperation between certain T and B lymphocyte subsets is also restricted (4) . Although this phenomenon of major histocompatibility complex (MHC) restriction is well established, it remains controversial whether the sharing of HLA class II molecules is an absolute prerequisite for effective cellular interactions. Moreover, the mechanism underlying the commitment to self-restricted MHC specificity remains unclear. Many hypotheses, especially concerning the role of the thymus in commitment to specificity, have been tested using either inbred animal models or in vitro human models (5) (6) (7) (8) . As yet, no clear consensus view has emerged. We have studied specific Ab production in a patient suffering from SCID in whom full immunological reconstitution was achieved after FLTT. Despite complete HLA mismatch between donor T cells and host cells, the patient was shown to respond in vivo to TT after immunization (9) . This observation suggested, in contrast to the present concept of genetic restriction, the possibility ofcellular cooperation across the allogeneic barrier in long-term human chimeras.
The present study was undertaken (a) to define whether anti- ( 14) .
Cell separations and culture conditions. PBMNC were isolated from heparinized blood by Ficoll-Hypaque gradient centrifugation. Cells were cultured in RPMI-1640 medium (Gibco, Irvine, United Kingdom) supplemented with 2 mM L-glutamine (Gibco), 100 U/ml penicillin, 100 gg/ml streptomycin (Gibco) and selected heat-inactivated fetal calf serum (Industrie Biologique Franoaise, Genevilliers, France). Assays , La Jolla, CA) was added to each well. After 2 h incubation at room temperature and four subsequent washings, substrate was added to each well (1 mg/ml paranitrophenyl phosphate in 0.9 M diethanolamine buffer, pH 9.8, containing 0.5 mM MgCI2).
Optical density values for each well were determined using a micro ELISA autoreader (MR 580, Dynatech Laboratories, Inc.). Each supernatant was assayed in duplicate. Each serum was assayed at several dilutions. The dose-response relationship for dilution of serum was linear for all samples within the range 1:250-1:250,000. The amount of anti-TT IgG was determined by comparison to a standard curve constructed using a human anti-TT Ig preparation (125 IU/ml; Gamma T. S. Antitetaniques, Cnts, Lyon, France). The absolute anti-TT Ab concentration ofthe standard Ig preparation was calibrated using affinity-purified anti-TT Ab. All values were calculated in international units per milliliter of TT Ab using the Gamma TS standard, and subsequently converted to absolute units after calibration of the standard (1 ng anti-TT Ab = 5 X l0o-IU).
The sensitivity of the ELISA, defined as being equal to the value at a point on the standard assay curve two standard deviation from the mean zero binding value, was 0.1 ng/ml. IgM anti-TT Ab, for which no purified preparation was available, were expressed as arbitrary units per milliliter by comparison with a laboratory standard.
The specificity of the TT Ab determination by ELISA was tested by adding soluble Ag (10 ug/ml or more) to culture supernatants 2 h before assay. Total IgG and IgM were measured in a similar manner to that already described except that plates were coated with rabbit anti-human y-chain or rabbit anti-human u-chain, respectively (Calbiochem-Behring Corp.). The amount of total Ig was determined by comparison with a standard curve constructed using known amounts of purified IgM and IgG.
Affinity purification ofanti-TTIg standard. Purified TT was dialyzed overnight against 0.1 M NaHCO3, pH 8.3, containing 0.5 M NaCl. The Ag was then incubated with CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals, Uppsala, Sweden) overnight at 4°C. Residual active sites were blocked with 0.2 M glycine, pH 8.0. The absorbent was then washed alternatively with high and low pH buffer (0.1 M acetate buffer, pH 4, containing 0.5 M NaCl, followed by coupling buffer, pH 8.3). The sample to be purified was diluted in PBS, pH 7.2, then incubated overnight at 4°C with end over end rotation. The gel was then packed into a column and unbound material washed out with PBS. Specific elution was carried out using 0.2 M glycine buffer, pH 2. yr after the transplant, the patient's PBMNC were studied with the ninth workshop antisera and the split chimerism was confirmed. All B lymphocytes and monocytes were shown to be of host origin, whereas the T lymphocytes were donor derived (Table I). There was no indication of the presence of donor HLA antigens in the monocytes and B cell populations. In contrast, all T lymphocytes expressed the donor's HLA antigens.
Immunoglobulin allotype
In order to determine whether the Ab produced were of donor or host origin, Ig allotyping was carried out in serum from the patient and his parents. The results showed that the patient's Ig had genetic markers compatible with parental Ig allotypic markers (Table II) . The patient's genotype consisted oftwo haplotypes present in the parental pool: Gm3, 23, 10, and 11, corresponding to the father, and Gml, 10, and 11 corresponding to the rare allotype ofthe mother. No nonparental allotypes could be identified.
Determination ofanti-TT antibodies
Specific anti-TT antibody levels were detected in sera and PBMNC culture supernatants by ELISA. In Fig. 1 , a mean ELISA IgG standard curve averaged from 25 experiments is shown. The SD values indicate that good interassay reproducibility was obtained.
As described previously, the absolute quantification of specific IgG was calculated by calibration of the anti-TT standard using an affinity-purified anti-TT IgG. We found that 1 ng of specific anti-TT IgG was equal to 5 X 10-5 IU. Specific antibody levels > 2 ng/ml were considered to be significant.
(a) In vivo anti-TT antibody levels. To determine anti-TT IgG levels in healthy donors after booster, nine subjects were reimmunized. The anti-TT IgG levels in serum ranged from 104 ,gg/ml to 242 ,g/ml 2 wk after booster. No significant differences between adult and child controls were noted. In the patient, the serum anti-TT Ab titer was 4 ,ug/ml before the last booster. The serum Ab titer rose to 24 ,g/ml at 2 wk after this booster. 6 wk after boostering the serum antibody level was 12 ug/ml.
(b) In vitro anti-TT Ig synthesis in normal donors. PBMNC from healthy donors were isolated 2, 4, and 6 wk after TT booster and cultured in the presence of TT. The highest Ag and PWM inducible TT specific responses were found at 2 wk and progressively decreased thereafter. Fig. 2 shows the geometric means of anti-TT Ab production 2 wk after immunization in seven control individuals. No correlation between in vitro Ab synthesis and in vivo Ab levels was observed. Maximal Ab concentration in culture supernatants were found using either 1 or 2 X 106 cells/ml. In cultures induced with Ag, the IgG peak response was obtained at TT concentration between 1 ng and 50 ng/ml. When TT was present during culture at concentrations > 50 ng/ml, the level of specific Ab detectable by ELISA began to decline and was virtually absent at concentrations > 1 ug/ml. No significant specific IgM production in response to TT was found. PWM also induced Ag-specific IgG production. In addition, minimal quantities of specific IgM were produced.
The specific anti-TT IgG response to PWM was stronger, similar to or lower than the Ag-stimulated response, depending on the donors. Two control donors failed to respond significantly to TT in vitro, despite the in vivo presence of normal levels of TT-specific IgG. In both cases, anti-TT Ab production in re- Addition ofcycloheximide to in vitro cultures inhibited Aginduced Ab production by >90%, demonstrating the de novo nature ofAb synthesis. However, in cultures without Ag, a certain amount ofspecific Ab was present. A portion ofthis background was due to spontaneous specific antibody synthesis in vitro by cells activated in vivo, since a partial inhibition was induced by cycloheximide.
(c) In vitro anti-TT synthesis in the patient. In vitro anti-TT Ab production by patient's PBMNC was measured 2 and 4 wk after the first booster given during this study and 2 and 6 wk after a second booster. In Fig. 3 , the in vitro specific anti-TT Ab production after the first booster is shown. Specific anti-TT IgG synthesis was found after PWM stimulation, but both spontaneous and TT-induced Ab production were completely absent. Similar results were obtained for IgM production (data not shown). At 4 wk postimmunization, the spontaneous and Aginduced Ab synthesis were essentially comparable with those found after 2 wk. The small amount of anti-TT IgG and IgM present in cultures induced by PWM was lower than that found at 2 wk.
In Fig. 4 , the in vitro culture results obtained at 2 and 6 wk after the last immunization are shown. At 2 wk, both a spontaneous and a TT-induced production of specific IgG were observed. The levels of Ab production and the Ag dose-response relationship were very similar to those found in the normal control group (Figs. 4 and 2, respectively). The peak specific Ab response was obtained at an Ag concentration of 1 ng/ml, and declined to background levels at 100 ng/ml. The PWM response was similar to that found after the first immunization. 6 wk after booster, Ab synthesis was still induced by both Ag and PWM, TETANUS TOXOID CONCENTRATION ** l g/ml PWM. t4 ,ug/ml (ng/ml) PWM. but the magnitude of the Ag-induced response was significantly lower than that found at 2 wk. The de novo Ab synthesis was confirmed by the inhibition of Ab production in cultures containing cycloheximide.
In vitro polyclonal Ig synthesis in the patient and controls
To determine whether the anti TT Ab found in cultures stimulated with low concentration of TT (1-50 ng/ml) represented a fraction of a polyclonal response, polyclonal Ig levels were determined by ELISA. Significant polyclonal IgG and IgM production was observed only in cultures with concentrations of Ag > 1 gg/ml. (Table III) . In cultures carried out 2 wk after the second booster given during the study, at the low TT concentration which induced the highest specific Ab synthesis level, no increase in polyclonal IgG and IgM could be detected. These results indicate that the specific anti-TT Ab response obtained at low TT concentrations is a result of Ag-specific interactions between the different cell populations.
Antigen-specific T cell proliferation
The TT specific proliferative T cell responses in this patient were also investigated and compared with those ofnormal donors immunized with TT. The time after booster immunization, at which blood cells were collected, varied between donors. Although high background proliferation was obtained in some experiments, both normal donors and patient lymphocytes presented significant TT-specific proliferative response as shown in Table IV . Stimulation indices ranged from 2.2 to 6. Proliferation generally reached a peak at an Ag concentration of 10 ,ug/ml.
Discussion
In the present paper we describe the in vivo and in vitro response to TT in an immunodeficient child transplanted with fetal tissue 7 yr previously. After FLTT, the subject developed a split chimerism. The present HLA phenotype of PBMNC shows that all T lymphocytes are of donor origin, while B lymphocytes and monocytes are of host origin. It is of interest that previous HLA typings, performed in a 4-yr period after transplantation, revealed the presence oftwo monocyte populations, one expressing donor phenotype, and the other expressing recipient phenotype. However, transplant-derived monocytes were found to disappear progressively from peripheral blood and were not detectable on many occasions tested in the last 3 yr. Despite persisting engraftment of only T cells, full immunological reconstitution was achieved in the patient. The clinical follow-up demonstrated that this chimeric state did not prevent the occurrence of clinically normal immune responses. The quality and stability of this reconstitution have resulted in good health and normal development during the 7 yr since FLTT. The subject presented a normal defence against pathogenic microorganisms such as fungi, bacteria, and viruses. In addition, he was found to mount a subnormal to normal in vivo Ab response after vaccination with a variety of viral and bacterial Ag including TT (1, 9) .
The results of Ig allotype determination strongly indicate that Ab are synthetized by host B cells. Serum Ig from the patient have an allotype compatible with that found in his parents. The Gml, 10, 11 allotype, found both in the patient and his mother, is extremely rare in Caucasians (Dr. L. Rivat, personal communication). Therefore, it is unlikely that Ig with this allotype are derived from transplanted B cells. These results eliminate the possibility that Ab were synthetized by a small population of donor-derived B lymphocytes that could not be detected by HLA typing.
To determine whether the in vivo Ab response resulted from cooperation between the patient's cells and donor-derived T cells, the in vitro anti-TT IgM and IgG-specific Ab production by PBMNC was investigated. Results were compared with those obtained in healthy donors.
Specific Ab synthetized by normal individuals were almost completely ofIgG isotype and occurred at low Ag concentrations, at which no polyclonal Ig synthesis was observed. At Ag concentrations > 1 lug/ml, specific Ab production was virtually absent. This might result either from the formation of immune complexes or from a suppressive mechanism as it has been observed in in vitro Ag pulsing experiments (17) .
TT was found to induce an increase in total in vitro Ig production when present at high concentrations. A similar observation has been described (12) . This could be due to a nonspecific activation of helper T cells with release of T cell factors that result in polyclonal B cell activation. In the patient, in vitro Aginduced Ab synthesis was observed after the last in vivo booster.
In experiments performed after the first immunization given during this study, anti-TT Ab synthesis was detectable only in cultures stimulated by PWM. The spontaneous and Ag-driven synthesis of IgG and IgM were completely absent. This may be attributed to the fact that PWM and TT induce the activation of different populations of cells, and that the frequency of cells able to respond to PWM is higher than that able to respond to Ag. A comparable difference in frequence has been described for antigen-specific precursor T cells by Lane et al. (18) . Such a difference may also exist at the level of recirculating memory B cells (19) .
The results obtained after the last immunization demonstrate the ability ofthe patient to synthetize specific Ab in response to TT in vitro after repeated in vivo Ag stimulation.
2 wk after the last booster, a significant amount of anti-TT Ab was synthesized in vitro after either TT or PWM stimulation. Moreover, the in vitro specific response was still present 6 wk after this immunization. The Ab synthesis present in vitro was not the result of a polyclonal B cell activation by a nonspecific positive allogeneic effect, since the response was Ag specific (20) . In the absence of TT, background specific Ab production was not significantly different from normal subjects. The Ag doseresponse curve for the patient was comparable with that found in the control group. Involvement of Ag-specific cellular cooperation was further demonstrated by the presence of a TT-induced proliferative response. Additionally, the in vivo and in vitro tolerance observed between donor T lymphocytes and host cells, and the in vitro results obtained after the first in vivo immunization exclude the possibility that our data are due to an allogeneic effect.
Although (24) , recently described a human bone marrow chimera in whom haplotype mismatched donor T cells could cooperate with recipient monocytes resulting in proliferative response to Ag (24) . Here we show that cell cooperation occurs in a situation in which HLA incompatibility is apparently complete. Ab was produced despite the absence of determinants shared by donorderived T lymphocytes and recipient cells at the HLA A, B, C, and DR loci. These data, in addition to the previously documented T cell functions of the chimeric child (1) have led us to postulate that the patient's T lymphocytes recognize antigens in association with allogeneic HLA determinants; we have designated this phenomenon the "Allo + X" recognition (1). According to this concept, a variety ofcells ofthe T lineage develop in the thymus, some with self HLA recognition, others with allo HLA recognition. In normal individuals, the former cells are much more frequent and the latter are barely detectable. In sustained HLA mismatched chimeras, persistent stimulation ofdonor-derived lymphocytes results in expansion of this population, which then develop the full repertoire of Ag recognition in association with the allogeneic HLA determinants of the host.
Slow immunological reconstitution after transplant could be explained by the time required for clonal expansion ofT cells which recognize allogeneic HLA determinants. It is possible that this population of cells, able to recognize Allo + Ag can not readily reach the same size as that of cells programmed to recognize Self + Ag. The resulting quantitative difference may account for the requirement of a repeated in vivo Ag stimulation for the induction of optimal Ab production in vitro. This interpretation is supported by results obtained from both the murine and human systems (25, 26) , which demonstrate the existence of both self and allo-restricted T cell precursors in the normal T cell repertoire. The final restricted recognition expressed by circulating cells may simply result from selection between cells with predetermined restriction specificity. Further studies to confirm this hypothesis are now under progress by investigating the interactions of host TT-specific B cell lines, as APC, with donor TT-specific T cell clones.
Moreover, at present we can not exclude the possibility that other D region determinants (27) are shared by donor and host cells, enabling cooperation to occur between these apparently totally mismatched cells.
In summary, we observed an in vivo and in vitro production of anti-TT Ab in a chimeric patient in which all detectable T cells are of donor origin and all B cells and monocytes are of host origin. Ab are synthetized by the host B cells. The ability of donor T cells to cooperate with recipient B cells and monocytes, resulting in a specific Ab production against a thymusdependent Ag, suggest the existence of T lymphocytes bearing recognition structures for Allo + Ag. That such T cells have not been identified in normal individuals but are found in long-term chimeras suggests that, from an initially low frequency, these cells can be expanded by chronic stimulation.
